Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?
Weldon
M J
MJ
Department of Biochemical Medicine, St George's Hospital Medical School, London.
Maxwell
J D
JD
D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000276:immunology; D007413:Intestinal Mucosa / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology*; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology*; D018123:Receptors, Interleukin / Q000037:antagonists & inhibitors / Q000187:drug effects*
D018123:Receptors, Interleukin